Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
Early stage biotechnology company
AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.
Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
SiO2 Materials Science is a plastic container designing company.
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
Cerecor discovers, develops and commercializes neuroscience drugs.
BioIntervene is engages in drug discovery and development.
Tizona develops next-generation immunotherapies
Triplet is developing transformative therapies that treat repeat expansion disorders at their source.
Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.
TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
Blade Therapeutics is a discovery stage drug development company.
Tetherex Pharmaceuticals operates in the healthcare industry focusing on biotechnology business.
Aratana Therapeutics develops innovative therapies for the animal health industry.
Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
Sideris Pharmaceuticals is focused on the development of therapeutics for the treatment of transfusion-related iron overload.
CoStim Pharmaceuticals Inc. operates as a biotechnology company. It develops antibody agents for treatment of cancer. The company was
MPM Capital has invested in 49 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
MPM Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 17 different industry categories.
Among tracked funding rounds, ReNAgade Therapeutics received $300.0M in a Series A round. MPM Capital's total known invested capital is $3.9B.
MPM Capital's average investment size is $90.3M across its portfolio of 49 companies.
Recent MPM Capital portfolio additions include Firefly Bio, Deka Biosciences, AstronauTx, ReNAgade Therapeutics, Photys Therapeutics. These companies were founded in 2020 or later.